Literature DB >> 19911940

The HCAP gap: differences between self-reported practice patterns and published guidelines for health care-associated pneumonia.

Gregory B Seymann1, Lorenzo Di Francesco, Bradley Sharpe, Jeffrey Rohde, Peter Fedullo, Aaron Schneir, Christopher Fee, Kevin M Chan, Pedram Fatehi, Thuy-Tien Dam.   

Abstract

BACKGROUND: Health care-associated pneumonia (HCAP) is prevalent among hospitalized patients. In contrast to community-acquired pneumonia (CAP), patients with HCAP are at increased risk for multidrug-resistant organisms, and appropriate initial antibiotic therapy is associated with reduced mortality.
METHODS: An online survey was distributed to faculty and housestaff at 4 academic medical centers. The survey required respondents to choose initial antibiotic therapy for 9 hypothetical pneumonia cases (7 cases of HCAP and 2 cases of CAP). Answers were considered correct if the antibiotic regimen chosen was consistent with published guidelines. In addition, physicians rated their knowledge of current guidelines, as well as their level of agreement with guideline recommendations.
RESULTS: Surveys were sent to 1313 physicians with a response rate of 65% (n = 855). Respondents included physicians in the following categories: hospital medicine/internal medicine, 60%; emergency medicine, 25%; and critical care, 13%. Respondents selected guideline-concordant antibiotic regimens 78% of the time for CAP, but only 9% of the time for HCAP. Because mean scores for HCAP questions were extremely low (mean, 0.63 correct answers out of 7), differences in performance between groups were too small to be meaningful. Despite their poor performance, 71% of the respondents stated that they are aware of published guidelines for HCAP, and 79% stated that they agree with and practice according to the guidelines.
CONCLUSIONS: In this survey, physicians reported they were aware of, agreed with, and practiced according to published pneumonia guidelines; however, the overwhelming majority did not choose guideline-concordant therapy when tested.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19911940     DOI: 10.1086/648429

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  11 in total

1.  Screening high risk individuals for hepatitis B: physician knowledge, attitudes, and beliefs.

Authors:  Temitope Foster; Huiming Hon; Fasiha Kanwal; Steven Han; Brennan Spiegel
Journal:  Dig Dis Sci       Date:  2011-10-15       Impact factor: 3.199

2.  Treatment Trends and Outcomes in Healthcare-Associated Pneumonia.

Authors:  Sarah Haessler; Tara Lagu; Peter K Lindenauer; Daniel J Skiest; Aruna Priya; Penelope S Pekow; Marya D Zilberberg; Thomas L Higgins; Michael B Rothberg
Journal:  J Hosp Med       Date:  2017-11       Impact factor: 2.960

3.  Association of guideline-based antimicrobial therapy and outcomes in healthcare-associated pneumonia.

Authors:  Michael B Rothberg; Marya D Zilberberg; Penelope S Pekow; Aruna Priya; Sarah Haessler; Raquel Belforti; Daniel Skiest; Tara Lagu; Thomas L Higgins; Peter K Lindenauer
Journal:  J Antimicrob Chemother       Date:  2015-01-03       Impact factor: 5.790

Review 4.  Healthcare-associated Pneumonia and Aspiration Pneumonia.

Authors:  Kosaku Komiya; Hiroshi Ishii; Jun-Ichi Kadota
Journal:  Aging Dis       Date:  2014-02-08       Impact factor: 6.745

5.  Barriers to guideline-concordant antibiotic use among inpatient physicians: A case vignette qualitative study.

Authors:  Daniel Livorsi; Amber R Comer; Marianne S Matthias; Eli N Perencevich; Matthew J Bair
Journal:  J Hosp Med       Date:  2015-10-06       Impact factor: 2.960

6.  Management of primary immune thrombocytopenia, 2012: a survey of oklahoma hematologists-oncologists.

Authors:  Kaelyn H Lu; James N George; Sara K Vesely; Deirdra R Terrell
Journal:  Am J Med Sci       Date:  2014-03       Impact factor: 2.378

7.  JAID/JSC Guidelines for the Treatment of Respiratory Infectious Diseases: The Japanese Association for Infectious Diseases/Japanese Society of Chemotherapy - The JAID/JSC Guide to Clinical Management of Infectious Disease/Guideline-preparing Committee Respiratory Infectious Disease WG.

Authors:  Keiichi Mikasa; Nobuki Aoki; Yosuke Aoki; Shuichi Abe; Satoshi Iwata; Kazunobu Ouchi; Kei Kasahara; Junichi Kadota; Naoki Kishida; Osamu Kobayashi; Hiroshi Sakata; Masahumi Seki; Hiroki Tsukada; Yutaka Tokue; Fukumi Nakamura-Uchiyama; Futoshi Higa; Koichi Maeda; Katsunori Yanagihara; Koichiro Yoshida
Journal:  J Infect Chemother       Date:  2016-06-15       Impact factor: 2.211

8.  Severe community-acquired Enterobacter pneumonia: a plea for greater awareness of the concept of health-care-associated pneumonia.

Authors:  Alexandre Boyer; Brice Amadeo; Frédéric Vargas; Ma Yu; Sylvie Maurice-Tison; Véronique Dubois; Cécile Bébéar; Anne Marie Rogues; Didier Gruson
Journal:  BMC Infect Dis       Date:  2011-05-11       Impact factor: 3.090

9.  Development and implementation of a performance improvement project in adult intensive care units: overview of the Improving Medicine Through Pathway Assessment of Critical Therapy in Hospital-Acquired Pneumonia (IMPACT-HAP) study.

Authors:  Julie E Mangino; Paula Peyrani; Kimbal D Ford; Daniel H Kett; Marcus J Zervos; Verna L Welch; Ernesto G Scerpella; Julio A Ramirez
Journal:  Crit Care       Date:  2011-01-25       Impact factor: 9.097

10.  Clinical implications for patients treated inappropriately for community-acquired pneumonia in the emergency department.

Authors:  Scott T Micek; Adam Lang; Brian M Fuller; Nicholas B Hampton; Marin H Kollef
Journal:  BMC Infect Dis       Date:  2014-02-05       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.